cytarabine has been researched along with Cerebellar Ataxia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herzig, GP; Herzig, RH; Karanes, C; Lazarus, HM; Phillips, GL; Wolff, SN | 1 |
| Hines, JD; Winkelman, MD | 1 |
| Ohi, K; Tsuji, M; Yamada, N | 1 |
| Jarowski, CI; Saper, CB | 1 |
| Fishman, DJ; Herzig, GP; Herzig, RH; Lazarus, HM; Phillips, GL; Roessmann, U | 1 |
| Friedman, JH; Shetty, N | 1 |
| Antony, J; Bergin, M; Menser, MA; Procopis, PG; Shaw, PJ; Stevens, MM | 1 |
| Imura, H; Kato, Y; Tatsuoka, Y | 1 |
| Ettinger, LJ; Jones, GR | 1 |
9 other study(ies) available for cytarabine and Cerebellar Ataxia
| Article | Year |
|---|---|
High-dose cytosine arabinoside therapy for refractory leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Diseases; Cerebellar Ataxia; Cognition Disorders; Conjunctivitis; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Hemorrhage; Humans; Leukemia; Middle Aged | 1983 |
Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study.
Topics: Acute Disease; Adolescent; Adult; Aged; Cerebellar Ataxia; Cerebellar Cortex; Cerebellar Nuclei; Cerebellum; Cytarabine; Dose-Response Relationship, Drug; Eye Movements; Female; Humans; Leukemia; Male; Middle Aged; Nerve Degeneration; Nystagmus, Pathologic; Purkinje Cells | 1983 |
[Cytosine arabinoside-induced cerebellar ataxia model. (2). Roles of the 5-hydroxyindole compounds in the developmental cerebellum].
Topics: Animals; Cerebellar Ataxia; Cerebellum; Cytarabine; Disease Models, Animal; Indoles; Mice; Tissue Distribution | 1983 |
Leukemic infiltration of the cerebellum in acute myelomonocytic leukemia.
Topics: Adult; Cerebellar Ataxia; Cerebellar Neoplasms; Cerebellum; Cytarabine; Drug Therapy, Combination; Female; Humans; Injections, Intraventricular; Leukemia, Myeloid, Acute; Methotrexate; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 1982 |
Central nervous system toxicity of high-dose systemic cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Brain; Brain Diseases; Cerebellar Ataxia; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia; Male; Middle Aged; Purkinje Cells | 1981 |
Permanent cerebellar toxicity of cytosine arabinoside (Ara C) in a young woman.
Topics: Adult; Antimetabolites, Antineoplastic; Atrophy; Cerebellar Ataxia; Cerebellum; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Videotape Recording | 2001 |
Bulbar and pseudobulbar palsy complicating therapy with high-dose cytosine arabinoside in children with leukemia.
Topics: Adolescent; Bulbar Palsy, Progressive; Cerebellar Ataxia; Child; Cytarabine; Female; Humans; Injections, Intravenous; Jaundice; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Paralysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
Effect of DN-1417, a synthetic thyrotropin-releasing hormone analogue, on [3H]GABA binding in the cerebellum of ataxic rats.
Topics: Animals; Cerebellar Ataxia; Cerebellum; Cerebral Cortex; Cytarabine; gamma-Aminobutyric Acid; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Thyrotropin-Releasing Hormone | 1985 |
Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
Topics: Acute Disease; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Burkitt Lymphoma; Cerebellar Ataxia; Child; Child, Preschool; Cytarabine; Female; Gastrointestinal Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Neutropenia; Recurrence; Thrombocytopenia | 1985 |